Volume 23, Number 9—September 2017
Dispatch
Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
Table 2
No. isolates |
Year isolated |
Origin |
CTX-M variant |
fosA type |
Sequence type |
Plasmid-carrying fosA type |
---|---|---|---|---|---|---|
9 | 2012 | Urine | CTX-M-55 | A3 | ST-559 (ST-10 complex) | FII, I1 |
12 | 2012 | Urine | CTX-M-55 | A3 | ST-559 (ST-10 complex) | FII, I1 |
36 | 2013 | Blood | CTX-M-55 | A3 | ST-1 (new) | FII |
19 | 2013 | Urine | CTX-M-15 | A3 | ST-2 (new) | FII |
34 | 2013 | Urine | CTX-M-2 | A3 | ST-2015 | Nontypeable |
24 | 2013 | Urine | CTX-M-15 | A3 | ST-4508 | FII |
35 | 2014 | Urine | CTX-M-15 | A3 | ST-69 | FII |
39 | 2014 | Joint fluid | CTX-M-15 | A3 | ST-69 | FII |
42 | 2015 | Urine | CTX-M-14 | A3 | ST-457 | colE nontypeable |
20 | 2015 | Feces | CTX-M-15 | A5 | ST-3 (new) | N |
*All genetic determinants were different except for isolates 9 and 12 (ST-559) and isolates 35 and 39 (ST-69). The yearly number of extended spectrum β-lactamase–producing E. coli screened was 1,044 in 2012, 1,142 in 2013, 1,251 in 2014, and 1,381 in 2015. ST, sequence type.
Page created: August 17, 2017
Page updated: August 17, 2017
Page reviewed: August 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.